Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,779,163
-$75,653 QoQ
Shares Held
65,808
+5.4% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Allworth Financial LP holds $13,612,825 across 48 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (57.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
65,808 | $7,779,163 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
46,558 | $2,406,583 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,507 | $1,120,712 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,083 | $642,197 | |
| 5 | VTRS |
Viatris Inc
|
21,979 | $296,936 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
12,733 | $235,815 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
16,116 | $223,206 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
8,810 | $210,823 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,779,163 | 65,808 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,854,816 | 62,429 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $6,910,693 | 47,230 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $7,357,565 | 47,179 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $7,144,163 | 43,390 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $7,121,670 | 43,710 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $480,439 | 2,459 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $542,790 | 3,131 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $537,241 | 3,175 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $570,793 | 2,892 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $525,245 | 3,019 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $456,012 | 2,648 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $443,729 | 2,666 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $363,004 | 2,477 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $381,105 | 2,570 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $487,136 | 2,834 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $548,985 | 2,911 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $650,583 | 2,666 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $368,089 | 1,896 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $144,988 | 778 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $144,251 | 916 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $154,411 | 933 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $151,478 | 916 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $104,972 | 766 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $76,027 | 646 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||